Patents Assigned to Mitokinin, LLC
  • Compositions and methods of using the same for treatment of neurodegenerative and mitochondrial disease
    Patent number: 10851109
    Abstract: The disclosure is directed to compounds and pharmaceutically acceptable salts thereof for the treatment and/or prevention of neurodegenerative and/or mitochondrial diseases, such as Parkinson's disease and Leigh's disease. The compounds and pharmaceutically acceptable salts thereof are of the class of nitrogenous bases, for example, pyrimidines, purines, pteridines, and pharmaceutically acceptable salts thereof.
    Type: Grant
    Filed: November 15, 2018
    Date of Patent: December 1, 2020
    Assignee: Mitokinin LLC
    Inventors: Daniel de Roulet, Robert Devita
  • Compositions and methods for treating neurodegenerative diseases and cardiomyopathy
    Patent number: 10723737
    Abstract: Disclosed herein inter alia are compositions and methods useful in the treatment neurodegenerative diseases and cardiomyopathy, and for modulating the activity of PINK1.
    Type: Grant
    Filed: February 21, 2017
    Date of Patent: July 28, 2020
    Assignees: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, MITOKININ LLC
    Inventors: Nicholas T. Hertz, Kevan M. Shokat, Robert DeVita
  • COMPOSITIONS AND METHODS USING THE SAME FOR TREATMENT OF NEURODEGENERATIVE AND MITOCHONDRIAL DISEASE
    Publication number: 20170190704
    Abstract: The present disclosure is directed, in part, to compounds, or pharmaceutically acceptable salts thereof, for the treatment and/or prevention of neurodegenerative disease and/or mitchonodrial disease including Parkinson's disease and Leigh's disease.
    Type: Application
    Filed: February 11, 2015
    Publication date: July 6, 2017
    Applicant: Mitokinin, LLC
    Inventors: Daniel de Roulet, Robert Devita